SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

The rough road has serious health implications as renal patients with kidney disease are forced to travel to and from ... mines and a shift towards FIFO and DIDO work, towns like Zeehan face a ...